BCL2A1 and hematopoietic and lymphoid system neoplasm: Another study screened an in-house compound library and identified ZH97 which can specifically bind to the C55 residue, block BFL-1/PUMA protein interactions, and induce apoptosis in BFL-1+ blood cancer cell lines [68].